BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND CDX2, CDX3, 1045, ENSG00000165556, Q99626 AND Treatment
25 results:

  • 1. A novel nomogram and risk stratification system predicting the cancer-specific survival of patients with gastric neuroendocrine carcinoma: a study based on SEER database and external validation.
    Song X; Xie Y; Lou Y
    BMC Gastroenterol; 2023 Jul; 23(1):238. PubMed ID: 37452300
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Rare occurrence of pseudomyxoma peritonei (PMP) syndrome arising from a malignant transformed ovarian primary mature cystic teratoma treated by cytoreductive surgery and HIPEC: a case report.
    Ponzini F; Kowal L; Ghafoor M; Goldberg A; Chan J; Lamm R; Cannaday SM; Richard SD; Nevler A; Lavu H; Bowne WB; Rosenblum NG
    World J Surg Oncol; 2022 Mar; 20(1):78. PubMed ID: 35272690
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical Approach to Neuroendocrine Neoplasm Associated With Ovarian Teratoma.
    Opalińska M; Sowa-Staszczak A; Olearska H; Ulatowska-Bialas M; Gilis-Januszewska A; Hubalewska-Dydejczyk A
    Front Endocrinol (Lausanne); 2021; 12():770266. PubMed ID: 34917031
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Retinoblastoma co-repressor 1 (RB) and cyclin-dependent kinase inhibitor (CDKN) as a multi-gene panel for differentiating pulmonary from non-pulmonary origin in metastatic neuroendocrine carcinomas.
    Krishnamurthy K; Cusnir M; Schwartz M; Sriganeshan V; Poppiti RJ
    Pathol Res Pract; 2020 Sep; 216(9):153051. PubMed ID: 32825935
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. NF1 optic pathway glioma: analyzing risk factors for visual outcome and indications to treat.
    Azizi AA; Walker DA; Liu JF; Sehested A; Jaspan T; Pemp B; Simmons I; Ferner R; Grill J; Hargrave D; Driever PH; Evans DG; Opocher E;
    Neuro Oncol; 2021 Jan; 23(1):100-111. PubMed ID: 32628746
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasis.
    Chorti E; Kanaki T; Zimmer L; Hadaschik E; Ugurel S; Gratsias E; Roesch A; Bonella F; Wessendorf TE; Wälscher J; Theegarten D; Schadendorf D; Livingstone E
    Eur J Cancer; 2020 May; 131():18-26. PubMed ID: 32248071
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Caudal Homeobox Gene-2 Staining Defines Intracranial Mature Teratoma with Differentiation to Colonic Adenocarcinoma.
    Riedy LN; Kim M; Yun JJ; Borys E; Prabhu VC
    World Neurosurg; 2019 Dec; 132():239-244. PubMed ID: 31520753
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Management of neuroendocrine tumors of unknown primary.
    Alexandraki K; Angelousi A; Boutzios G; Kyriakopoulos G; Rontogianni D; Kaltsas G
    Rev Endocr Metab Disord; 2017 Dec; 18(4):423-431. PubMed ID: 29199361
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic value of metabolic indices and bone marrow uptake pattern on preoperative 18F-FDG PET/CT in pediatric patients with neuroblastoma.
    Li C; Zhang J; Chen S; Huang S; Wu S; Zhang L; Zhang F; Wang H
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):306-315. PubMed ID: 29110068
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Yolk Sac tumor in Extragonadal Pelvic Sites: Still a Diagnostic Challenge.
    Ravishankar S; Malpica A; Ramalingam P; Euscher ED
    Am J Surg Pathol; 2017 Jan; 41(1):1-11. PubMed ID: 27631522
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Characteristics, treatment and outcomes of women with immature ovarian teratoma, 1998-2012.
    Jorge S; Jones NL; Chen L; Hou JY; Tergas AI; Burke WM; Ananth CV; Neugut AI; Herhshman DL; Wright JD
    Gynecol Oncol; 2016 Aug; 142(2):261-6. PubMed ID: 27222024
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The Effects and Molecular Mechanisms of MiR-106a in Multidrug Resistance Reversal in Human Glioma U87/DDP and U251/G cell Lines.
    Wang Q; Wang Z; Chu L; Li X; Kan P; Xin X; Zhu Y; Yang P
    PLoS One; 2015; 10(5):e0125473. PubMed ID: 25950430
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Specialized surveillance for individuals at high risk for melanoma: a cost analysis of a high-risk clinic.
    Watts CG; Cust AE; Menzies SW; Coates E; Mann GJ; Morton RL
    JAMA Dermatol; 2015 Feb; 151(2):178-86. PubMed ID: 25389712
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. KRAS mutation in adenocarcinoma of the gastrointestinal type arising from a mature cystic teratoma of the ovary.
    Li Y; Zhang R; Pan D; Huang B; Weng M; Nie X
    J Ovarian Res; 2014 Sep; 7():85. PubMed ID: 25297496
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Uveal melanoma: A pathologist's perspective and review of translational developments.
    Schoenfield L
    Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Endoscopic submucosal dissection for foregut neuroendocrine tumors: an initial study.
    Li QL; Zhang YQ; Chen WF; Xu MD; Zhong YS; Ma LL; Qin WZ; Hu JW; Cai MY; Yao LQ; Zhou PH
    World J Gastroenterol; 2012 Oct; 18(40):5799-806. PubMed ID: 23155323
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Molecular pathology of gastric carcinoma.
    Jang BG; Kim WH
    Pathobiology; 2011; 78(6):302-10. PubMed ID: 22104201
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A PCR/restriction digestion assay for the detection of the transcript variants 1 and 2 of POU5F1.
    Panagopoulos I; Möller E; Isaksson M; Mertens F
    Genes Chromosomes Cancer; 2008 Jun; 47(6):521-9. PubMed ID: 18335506
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Primary neuroendocrine carcinoma of the liver. From carcinoid tumor to small-cell hepatic carcinoma: case reports and review of the literature].
    Balta Z; Sauerbruch T; Hirner A; Büttner R; Fischer HP
    Pathologe; 2008 Feb; 29(1):53-60. PubMed ID: 18210116
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. CD8+ T cells against multiple tumor-associated antigens in peripheral blood of midgut carcinoid patients.
    Vikman S; Giandomenico V; Sommaggio R; Oberg K; Essand M; Tötterman TH
    Cancer Immunol Immunother; 2008 Mar; 57(3):399-409. PubMed ID: 17717663
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.